SCHEMBL24457969

SCHEMBL24457969

Cc1cc(F)cc2c1NCC2

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PARP10 Q53GL7 4/20 0.37
▸ PARP1 P09874 2/20 0.37
▸ GRM5 P41594 2/20 0.34
▸ PARP11 Q9NR21 2/20 0.33
▸ F12 P00748 5/20 0.32
▸ HTR2A P28223 1/20 0.32
▸ HTR2C P28335 1/20 0.32
▸ CASP1 P29466 2/20 0.31
▸ CASP7 P55210 2/20 0.31
▸ KDM4E B2RXH2 1/20 0.31
▸ ALDH1A1 P00352 1/20 0.31
▸ LMNA P02545 1/20 0.31
▸ GLA P06280 1/20 0.31
▸ GAA P10253 1/20 0.31
▸ HPGD P15428 1/20 0.31
▸ HSD17B10 Q99714 1/20 0.31
▸ NISCH Q9Y2I1 1/20 0.31
▸ MEN1 O00255 1/20 0.30
▸ CYP1A2 P05177 1/20 0.30
▸ CRHBP P24387 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22702928 0.89 KDM4E (0.39) PARP1F12CASP1CASP7KDM4E
SCHEMBL2261586 0.79 PARP10 (0.39) PARP10PARP1GRM5PARP11HTR2A
SCHEMBL17433704 0.79 PARP10 (0.43) PARP10PARP1GRM5PARP11HTR2A
SCHEMBL24457967 0.77 PARP10 (0.42) PARP10PARP1PARP11HTR2AHTR2C
SCHEMBL16593595 0.76 PARP10 (0.37) PARP10PARP1GRM5PARP11
SCHEMBL24457975 0.76 MEN1 (0.41) PARP10PARP1GRM5PARP11HTR2A
SCHEMBL8648955 0.76 PARP10 (0.41) PARP10PARP1PARP11HTR2AHTR2C
SCHEMBL8651032 0.76 DRD2 (0.46) PARP10PARP1PARP11CASP1CASP7
SCHEMBL24457970 0.73 DRD2 (0.40) PARP10PARP1GRM5PARP11ALDH1A1
SCHEMBL10300799 0.73 PARP1 (0.35) PARP10PARP1GRM5HTR2AHTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022109001-A1 GCN2 AND PERK KINASE INHIBITORS AND METHODS OF USE THEREOF DECIPHERA PHARMACEUTICALS, LLC (US) 2022-05-27 — — WO disclosed
Send feedback